Apollon Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.09M Sell
5,873
-73
-1% -$40.9K 0.04% 395
2026
Q1
$3.34M Buy
5,946
+267
+5% +$171K 0.05% 279
2025
Q4
$3.84M Buy
5,679
+76
+1% +$51.8K 0.07% 246
2025
Q3
$3.58M Buy
5,603
+9
+0.2% +$5.46K 0.06% 253
2025
Q2
$3M Buy
5,594
+7
+0.1% +$3.35K 0.06% 279
2025
Q1
$2.35M Buy
5,587
+257
+5% +$112K 0.05% 294
2024
Q4
$2.2M Sell
5,330
-2,027
-28% -$889K 0.05% 320
2024
Q3
$3.72M Buy
7,357
+691
+10% +$336K 0.11% 176
2024
Q2
$3.25M Buy
6,666
+328
+5% +$165K 0.1% 188
2024
Q1
$3.42M Buy
6,338
+222
+4% +$121K 0.11% 169
2023
Q4
$3.39M Buy
6,116
+1,585
+35% +$744K 0.12% 164
2023
Q3
$1.98M Buy
4,531
+210
+5% +$105K 0.1% 194
2023
Q2
$2.17M Sell
4,321
-184
-4% -$88.2K 0.1% 203
2023
Q1
$2.25M Sell
4,505
-72
-2% -$34.5K 0.14% 153
2022
Q4
$1.87M Buy
4,577
+529
+13% +$205K 0.13% 167
2022
Q3
$1.32M Buy
4,048
+505
+14% +$186K 0.11% 201
2022
Q2
$1.24M Buy
3,543
+42
+1% +$17.1K 0.1% 219
2022
Q1
$1.92M Buy
3,501
+187
+6% +$98.4K 0.14% 161
2021
Q4
$2.18M Buy
3,314
+2,978
+886% +$1.87M 0.16% 145
2021
Q3
$209K Buy
336
+5
+2% +$3.36K 0.03% 427
2021
Q2
$209K Buy
+331
New +$183K 0.04% 344

Other funds holding IDXX

Apollon Wealth Management's IDXX Position: Q2 2026 in Review

Apollon Wealth Management reduced its Idexx Laboratories (IDXX) stake by 1.2% in Q2 2026, selling an estimated $40.9K and leaving 5,873 shares worth $3.09M. The position accounts for 0.04% of the portfolio, ranked #395.

Apollon Wealth Management first reported a position in IDXX in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.84M in Q4 2025. 328 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Apollon Wealth Management held 5,873 shares of Idexx Laboratories worth $3.09M as of Q2 2026.
  • Apollon Wealth Management sold 73 Idexx Laboratories shares in Q2 2026, an estimated $40.9K.
  • Idexx Laboratories made up 0.04% of Apollon Wealth Management's portfolio in Q2 2026, its #395 holding.
  • Apollon Wealth Management first reported a position in Idexx Laboratories in Q2 2021 and has held it in 21 quarters since.
  • Apollon Wealth Management's Idexx Laboratories position peaked at $3.84M in Q4 2025.
  • 328 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.